Shree Ganesh Bio-Tech (India) Limited Schedules Board Meeting on May 14, 2026 to Approve FY26 Audited Financial Results
Shree Ganesh Bio-Tech (India) Limited has informed stock exchanges of a board meeting to be held on May 14, 2026, under Regulation 29 of SEBI (LODR) Regulations, 2015. The meeting's primary agenda is to approve the audited standalone financial results for the quarter and year ended March 31, 2026, along with auditor reports. The intimation was filed with BSE Limited, The Calcutta Stock Exchange Ltd, and Metropolitan Stock Exchange of India Limited, and was signed by Director Aman Patel on May 4, 2026.

*this image is generated using AI for illustrative purposes only.
Shree Ganesh Bio-Tech (India) Limited has notified the stock exchanges of an upcoming board meeting scheduled for Thursday, May 14, 2026, pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The intimation, dated May 4, 2026, was submitted to BSE Limited, The Calcutta Stock Exchange Ltd, and Metropolitan Stock Exchange of India Limited.
Board Meeting Agenda
The board meeting has been convened to transact the following key business:
| Agenda Item: | Details |
|---|---|
| Financial Results: | Approve and take on record the Audited Standalone Financial Results for the quarter and year ended March 31, 2026 |
| Auditor Reports: | Consider reports of the Auditors on the standalone financial results |
| Other Business: | Any other matter with the permission of the board as deemed fit |
Regulatory Compliance
The intimation has been filed in accordance with Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which mandates listed companies to notify stock exchanges in advance of board meetings where financial results are to be considered. The notice was duly signed by Aman Patel, Director of Shree Ganesh Bio-Tech (India) Limited.
Exchange Notifications
The company submitted the board meeting intimation to the following exchanges:
- BSE Limited, P J Tower, Dalal Street, Mumbai
- The Calcutta Stock Exchange Ltd, Kolkata
- Metropolitan Stock Exchange of India Limited, Mumbai
The filing was made on May 4, 2026, ahead of the scheduled board meeting date of May 14, 2026.
Historical Stock Returns for Shree Ganesh Bio-Tech
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -3.17% | 0.0% | +1.67% | -16.44% | -34.41% | -89.85% |
How might Shree Ganesh Bio-Tech's FY2026 annual financial results compare to the previous year in terms of revenue growth and profitability margins?
Could the board meeting on May 14, 2026 potentially include announcements beyond financial results, such as dividend declarations or strategic expansions in the biotech sector?
How has Shree Ganesh Bio-Tech's stock performance on BSE trended leading up to this results announcement, and what are analyst expectations for the company?





























